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a b s t r a c t
Percutaneous coronary intervention (PCI) in bifurcation lesions is associated with lower
success rate, higher acute complication rates and higher event rates in follow-up.
The reason for this higher than usual complication rate relates to the relationship
between anatomy, ﬂow, and atheroma distribution in bifurcation lesions.
Further, stenting these lesions can be a prolonged procedure and can be technically more
demanding. The most common complication is the loss of signiﬁcant side branch (SB). Main
vessel (MV) stenting may enhance the carina displacement and atheroma shift across the SB
ostium leading to SB ostium narrowing.
Finally, complications, if they occur, are more difﬁcult to manage. Dedicated bifurcation
stent has been developed to overcome the number of limitations associated with conven-
tional bifurcation PCI. The main advantage of most dedicated bifurcation stents is to allow
the operator to perform the procedure on a bifurcation lesion without the need to rewire the
SB.
# 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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journal homepage: www.elsevier.com/locate/ihj1. How bifurcation lesion is mechanistically
different from other lesions?
Blood ﬂow through a bifurcation vessel is governed by the
ramiﬁcation law of the epicardial coronary tree which simply
means that there is a good correlation between side branch
(SB) diameter and length and the mass supplied by this vessel.
Thus, longer and larger diameter vessels have more blood
ﬂowing through them.2
Three diameters rule: The size of a vessel (as also the ﬂow
through it) is dictated by the three-diameter rule which states
that the relation between true size of the main branch (MV)
and distal main branch (DMV) and side-branch (SB) can beE-mail address: drsundeepmishraihj@gmail.com.
http://dx.doi.org/10.1016/j.ihj.2015.07.054
0019-4832/# 2016 Published by Elsevier B.V. on behalf of Cardiologica
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).dictated by scaling laws like Murrays's Law ({MV} =
{DMV}3 + {SB},3 or simplistically by Law of Finet which states
that size of MV is 2/3rd of sum of both the distal branches
(MV = 0.678{DMV + SB})1,2.
Atheroma distribution and thrombus formation in bifurcation
lesion: The atheroma distribution in bifurcation situation is
also different from non-bifurcation areas. Physiologically
atheroma is distributed in the areas of: (a) low endothelial
shear stress (inner areas of curvatures, upstream of stenosis)
and (b) oscillatory endothelial shear stress (lateral wall of
bifurcation, downstream of stenosis, irregular arterial regions,
branch points: plaques are located opposite the SB take-off and
are more concentric proximal to the SB and more eccentric just
distal to side-branch). The plaques are also inﬂuenced by thel Society of India. This is an open access article under the CC BY-
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acute angle (toward an inner radius of curvature) and away
from obtuse angle. Atheroma is less common in the region of
carina but more common where there is wide bifurcation
angle, increased ratio of SB dimension in relation to main
branch, or increased bifurcation tortuosity. On the other hand,
late stent thrombosis (ST) is more common in the areas of high
shear stress where less re-endothelisation occurs such as
carina.
As a consequence of all these mechanistic differences, the
outcomes of percutaneous coronary intervention (PCI) in these
subset of patients may be much different than non-bifurcated
lesions.
1.1. Correlates of clinical outcomes in bifurcation lesions
1. Final angiographic result in MV: this is generally the single
most important predictor of the clinical outcome. Thus,
many 2-stent strategies which lead to a high metal mass at
carina (which actually requires least scaffolding because
carina is the ﬂow divider with high shear stress and
therefore generally free of plaques), as also alter the ﬂow
dynamics but also go against the 3-diameter rule. That is
why most studies demonstrate that irrespective of type of
stents used and in all types of lesion classiﬁcations (except
for Medina 0, 0, 1, i.e. isolated SB stenosis or those lesions
with diffuse involvement of the SB), a single stent strategy is
nearly always better than a 2-stent strategy.3 The superior-
ity lies in lower peri-procedural MI and possibly lower major
adverse cardiac event (MACE), restenosis and ST rates as
also in lower procedural time, contrast volume and
radiation exposure with provisional SB stenting strategy.
The 2-stent strategy is especially associated with a worse
outcome if bifurcation angle is >508.
2. Result in the ostium of SB while not co-relative of major
events is still responsible for minor events. Thus, when SB is
important and diffusely diseased, it does increase require-
ment of re-intervention. Further, in some cases with a
single stent strategy, the SB may be irretrievably lost. In
those cases 2-stent strategy, which provides deﬁnitive
scaffolding of SB ostium may be useful.
1.2. When to use 2 stent strategies?
The major limitation of a single stent strategy is an inability to
provide enough scaffolding to the ostium of the SB, which can
lead to higher restenosis rate and higher need for target lesion
revascularization (TLR). Therefore, in those cases, where SB is
very important and likely to get compromised with 1-stent
only strategy, a 2-stent strategy may be required initially
(10% of cases). Possible situations where a 2-stent strategy
can be recommended to begin with are:
1. SB is large in diameter (>2.5 mm) and territory of distribu-
tion and there is a risk of hemodynamic deterioration, if SB
is lost (poor LVEF, distal left main).
2. SB has severe disease (>50%) that extends beyond the
ostium (10–20 mm or more).3. Have an unfavorable angle (narrow angle A: the angle
between proximal MV and SB) for re-crossing after MV stent
implantation.N.B. Remember that when angle A is narrow
(<1208), insertion of guidewire increases the angle by an
average of 338.
1.3. How to choose 2 stent strategies?
1. Strategies with minimal metal overlap of 2 stents are the
best: Mini-crush is better than classical crush because metal
overlap is less, residual metallic stenosis at ostium is less,
and there is a better scaffolding of ostium. The long-term re-
endothelization is also better, which may translate into
lower restenosis and late ST (most serious limitations of
classical crush). T stenting with minimal protrusion (TAP) is
better than classical T stenting, because there are fewer
gaps in ostial coverage (better scaffolding) leading to lower
restenosis.
2. If angle between the distal MV and SB (Angle B) is wide, a T
stenting type of strategy like TAP technique may be
preferable.
3. If angle between the distal MV and SB is narrow (<508), a V
type of strategy like Culottes or Mini Crush may be
preferable.
4. Culottes technique may be superior to classical crush
technique because of lesser risk of SB restenosis and can be
performed through a 6-F guide but is technically more
demanding. Moreover, it should not be performed, if there is
huge mismatch between the main and daughter vessels.
5. If the procedure has to be done quickly, a simultaneous
kissing stent (SKS) may be preferable, because this
technique is simple but requires an 8-F guide and produces
a metallic neo-carina upstream from the bifurcation that
may be prone to ST. Furthermore, if an upstream dissection
occurs, it will be difﬁcult to manage.
Thus several techniques have been proposed and used
successfully in the true bifurcation lesions.4
1.4. Limitations of current 2-stent strategies: need for
dedicated bifurcation stents
1. The main limitation of the current strategies is a high rate of
restenosis and re-intervention (in double ﬁgures) despite
the use of DES especially in SB even with best of the
techniques.
2. Higher risk of ST.
Difﬁculties in techniques and some mechanistic reasons
account for poor short- and long-term clinical outcomes are
(Table 1):
1. High metal mass where the two stents meet.
2. Irregular overlapping of struts at the carina.
3. Distorted SB stent.
4. Polymer rupture and uneven distribution of stent struts at
origin of the SB.
5. Noncompliance with 3-diameter rule and alteration in
natural ﬂow dynamics.
Table 1 – Mechanistic characteristics of two-stent techniques.
Characteristics T/TAP Culottes SKS Mini-crush
Change in ﬂow
dynamics
Very little Little change because double
layer of stent struts in
proximal MV
Maximum change in ﬂow
dynamics because of
formation of neo-carina in
the proximal MV and also by
presence of two additional
circulating channels at the
junction of two stents
implanted in this segment
Some change because of
crushed 3 layer of stents at
MV adjacent to SB osmium
Conformity with
3-diameter rule
(bifurcation
branching laws)
Somewhat compliant Less compliant because 2
layers of stent strut in
proximal MV
Most compliant Least compliant as 3 layers
of crushed stent struts
occluding the MV near the
osmium of SB
Apposition of
stent struts to
vessel wall
Impossible to optimally
scaffold the SB and at
the same time properly
appose stent in the MV
Good SB scaffolding can be
achieved but apposition of 2
stent struts to proximal MV
may be difﬁcult. If apposed
twice drug delivered to
proximal MV
Impossible to appose all
struts to vessel wall because
of formation of double barrel
which are also likely to
become entwined and also
formation of neo-carina
Good SB scaffolding, 3 layers
of struts are often
inadequately apposed to MV
predisposing to risk of stent
thrombosis. If they are
opposed adequately 3 times
drug delivered in MV
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These mechanistic limitations lead to several issues in long-
term outcomes; higher MACE, higher TLR, higher restenosis
rate, however, the most dreaded one is ST. However, several
studies have demonstrated that when properly done, the risk
is no greater when 2 stents versus 1 stent is used.5,6
Besides higher event rate, there may be several technical
difﬁculties with 2-stent techniques as well (Table 2).
1. Mal-orientation/apposition of MV stent (Side-hole stents).Table 2 – Technical characteristic.
Characteristics T/TAP Culottes 
Guiding catheter used (Fr) 6 (classical T), 7
(modiﬁed T
because 2
stents are
delivered
simultaneously)
6 
Provisional SB stenting possible Possible Possible, if ﬁrs
branch to be
stented is MV
Ease of handling: Number of
steps in the technique
5 7 (most
cumbersome)
Number of times rewiring done 1 2 
Layer of stent struts at the SB
(ease of crossing into SB)
1 2 
Bifurcation angle (B) <708 Not ideal Possible 
Bifurcation angle (B) >708 Ideal Possible (can
be used in
widest spectru
of angles)
Diameter of proximal and distal
MV nearly same (SB small)
Possible Not possible 
Re-intervention Easy Somewhat
difﬁcult2. SB access not guaranteed (Crush, Culottes technique).
3. Wire-wrap (double wire systems).
4. Difﬁculty in re-crossing deployed struts.
1.6. Role of dedicated bifurcation stents
In this context, dedicated bifurcation stents lead to excellent
results in the MV while providing excellent scaffold in SB as
well. Being a complete ﬁt, there are no anatomic or physiologic
challenges.SKS Mini-crush
7 or 8 (2 stents are
delivered simultaneously)
7 or 8 (2 stents are
delivered simultaneously),
6 Fr if double kiss crush is
performed
t Not possible Not possible
1 (easiest) 3, 6 if double kiss crush
performed
0 (rewiring not required) 1, 2 if double kiss crush is
performed
0 3
Possible Ideal
m
Not ideal Not ideal (MACE increases
with angle >508
Not possible Ideal
Difﬁcult to treat because
of formation of membrane
at neo-carina and possibility
of entwined double barrel
Somewhat difﬁcult
Table 3 – Classification of dedicated bifurcation devices.
Device system Variety
MB stenting with some SB scaffold Frontier
Pathﬁnder
Petal
Side-kick
Trireme
Twin-rail
Nile
Stentys
SB Stent Side-Guard
Tryton
Proximal bifurcation stent Axxess
True bifurcated stent Medtronic
Fig. 1 – Main vessel stent with side-branch scaffold.
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Dedicated bifurcation stents can be broadly divided into 4
categories: (A) MV stenting with SB scaffold; (B) SB stent with
MV access; (C) Proximal bifurcation stent, and (D) Bifurcated
stent (Table 3).
Mechanistically, bifurcation stents are divided into 2 types.
1. Stents for provisional SB stenting that facilitate or maintain
access to the SB after MB stenting, and do not require
recrossing of MB stent struts. These stents allow placement
of a second stent on the SB only if needed.
2. Stents that usually require another stent implanted in the
bifurcation. Generally these stents (TrytonTM and Side-
guardTM) are designed to treat the SB ﬁrst and then doing
the MV. However, at the end of the procedure they require
re-crossing into the SB for ﬁnal kissing balloon dilatation
(FKBD). On the other hand, Axxess PlusTM is ﬁrst implanted
in the proximal MV at the level of the carina and does not
require re-crossing into the SB but may require the
additional implantation of 2 further stents to completely
treat some types of bifurcation lesions.Table 4 – Advantages and disadvantages of main vessel stents
Alignment of devices Varieties Adva
Self alignment 1. Twin Rail 1. Simple to us
2. Nile 2. Intuitive alig
3. Petal 
4. Frontier 
5. Abbott SB
Controlled alignment 1. Trieme 1. Less wire w
2. Side-kick 2. Lower proﬁl
No alignment required 1. Stentys 1. No risk of w
misalignment
2. Lower proﬁl
3. Only 1 wire 2.1.1. MV stenting with SB scaffold
This is most popular approach to bifurcation stenting. It is
useful for all types of bifurcation lesions except only SB (001).
Here the priority is MV stenting; however, SB scaffold is
superior to provisional stenting. It improves drug delivery and
reduces the chance of stent and polymer fracture. However,
the main limitations are risk of wire wrap, risk of misalign-
ment, a relatively low procedural success: 85–92% and a long
learning curve. The advantages and disadvantages of these
stents are discussed in Table 4. Several stents of this type are
available: FrontierTM, PathﬁnderTM, PetalTM, Side-kickTM, Trir-
emeTM, Twin-railTM, NileTM, StentysTM, etc. (Fig. 1).
2.1.2. SB stent
These stents are speciﬁcally designed to secure the SB and are
useful only for true bifurcation lesions. The deliverability is
good, and there is no risk of wire wrap. Further, stent
positioning is relatively easy, and there is no need for stent
rotation to conform to conﬁguration of bifurcation. Finally, MV
access is really good. The only disadvantage is that one is
committed to 2-stent use; therefore, risk of peri-procedural MI with side-branch access.
ntages Disadvantages
e 1. Risk of wire wrap
nment by device 2. Risk of misalignment
3. Relatively low procedural success
4. Relatively long learning curve
rap 1. Three guidewires have to be inserted
e
ire wrap or
e
required
Fig. 2 – Nile PaxTM stent.
Fig. 3 – Deployment steps of Nile PaxTM stent. System positioned
main branch balloon dilated; (B) Side-branch balloon positioning;
required.
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available: Capella Side-GuardTM and TrytonTM.
2.1.3. Proximal bifurcation stent
Technically, this is the most ideal system of a bifurcation stent.
However, the only limitation is difﬁculty in accurately
positioning this stent.
2.1.4. Bifurcated stent
Bifurcated stent system is a novel platform designed repro-
ducibly to permit stenting in bifurcation lesions regardless of
branch angulation or plaque location, in a short simple
procedure. It consists of 2 balloon catheters and two stents;
the mother balloon catheter has a sleeve, through which and main branch balloon dilated. (A) System positioned and
 (C) Final kissing balloon dilatation; (D) Distal stents placed if
Fig. 5 – Steps in StentysTM stent deployment.
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loaded on two wires and both catheters can be simultaneously
or independently maneuvered. Two varieties are available: (1)
Medtronic Bifurcated Stent; (2) Advanced Bifurcation Systems.
Advantage of this system is that it can be a short simple
procedure; it can scaffold any bifurcation regardless of size,
angle, or plaque location. However, the disadvantages are that
the proﬁle is larger, because there is daughter balloon-stent
system inside mother balloon-stent system, ﬂexibility is less
and being a dual wire system, risk of wire wrap and
misalignment is high. Further, all the accompanying dis-
advantages of 2-stent strategy exist.
3. Bifurcation stent hardware and technique
3.1. Nile PaxTM
It is a Cobalt Chromium Alloy L605 available in 2 sizes (18 mm
and 24 mm). Its strut thickness is 73 mm, coated with 5 mm
polymer free abluminal paclitaxel (dose 2.5 mg/mm2) and it is
compatible with a 6F sheath. The size refers to total length of the
stent where the distal length (for the D MV) is 8 mm and the
remaining length is for MV I (Fig. 2). The stent has 3 radio-opaque
markers; one each at 2 ends and a central marker at SB tip.
3.2. Deployment sequence (Fig. 3 (A–D))
1. System is positioned.
2. Main branch balloon is dilated.
3. SB balloon is positioned.
4. FKBD.
5. Distal stents placed through the stent if required.
3.3. StentysTM
The STENTYSTM technology consists of a unique, self-
expanding nitinol stent platform. The STENTYS DES(P)TM
has a bio-stable, poly-sulphone (of polysulphone and soluble
polyvinylpyrrolidone) polymer which acts as an excipient
eluting Paclitaxel. The STENTYS BMS and DES(P) stents are
available in small (2.5–3.0 mm), medium (3.0–3.5 mm), and
large (3.5–4.5 mm) and in lengths 17 mm, 22 mm, and 27 mm.
The large size stent (indicated for vessels from 3.5 to 4.5 mm)
can even expand further up to over 6 mm. It is designed with
small distinctive interconnectors that can be utilized to create
an opening through the stent. Thus an ordinary DES stent canFig. 4 – Design aspects of StentysTM stent.be converted into a bifurcation stent (MV with SB access).
Technically, the procedure is like Provisional T but when the
stent is re-crossed by wire into SB and dilated with an
angioplasty balloon the stent interconnectors become discon-
nected and the stent converts into a bifurcation stent with MV
scaffold and side-branch access independent of the SB ostium
location. The interconnectors are placed all along the length
and the circumference of the stent, apart from the ﬁrst and last
2 mm. Further, its short, expandable segments and its self-
expansion feature allow for excellent vessel conformability as
well as continuous apposition along the arterial wall, superior
to existing balloon-expandable stents (Fig. 4).Fig. 6 – TrytonTM stent design.
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1. The stent is implanted in the MV over a single wire, like a
standard stent, without any speciﬁc positioning related to
the SB.
2. If access or treatment of the SB is required, a guidewire and
a balloon are advanced through the distal stent cell.
3. A low-pressure balloon inﬂation disconnects the intercon-
nectors and creates the opening – the self-apposingFig. 7 – Steps in TrytonTMproperty of the StentysTM stent allows the in situ modeling
of the stent to within the vessel (Fig. 5).
3.5. TrytonTM bifurcation device
It is 84 mm cobalt chromium balloon expandable bare metal
stent. It is available in 2 sizes: short (15 mm) and standard
(19 mm) compatible with 5F and 6F guide catheters. The stentstent deployment.
Fig. 7. (Continued ).
Fig. 8 – Markers on the AxxessTM stent.
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Technically, it has 3 zones. Zone 1: SB zone, which provides
superior scaffolding within the SB, securing it acting like any
workhorse stent. Zone 2: It is the Transition zone, which
provides radial strength and complete coverage to the SB and
ostium regardless of bifurcation angle and geometry. Zone 3:
Main Branch zone, which because of minimal metal to artery
ratio (M:A) allows seamless integration with SB stent. If
required, a DES can be placed in this zone (Fig. 6).
3.6. Deployment sequence
1. Both MV and SB are wired.
2. SB is predilated.
3. Position TrytonTM SB stent 50% in MV and 50% in SB.
4. Deploy TrytonTM SB stent.
5. Post-dilate TrytonTM proximal segment with balloon sized
to MV diameter but also extending till SB ostium.
6. The TrytonTM stent is deployed and the SB secured and
protected.
7. Park the balloon within TrytonTM stent and wire the main
branch with the wire in SB.
8. Check that the ‘‘parked’’ balloon passes easily to DMV and
dilate the transition zone with it.
9. Position MV DES 1 mm proximal to SB arm of TrytonTM
stent to ensure optimal scaffolding.
10. After properly positioning the MV DES removed the jailed
MV wire.
11. Deploy MV stent.12. Rewire SB.
13. Perform FKBD (Fig. 7).
3.7. Axxess PlusTM
The AxxessTM stent is made from a self-expanding nitinol in
the austenitic (superelastic) phase. The stent elutes Biolimus
A9 (which has the highest lipophilicity among the common
limus group of drugs). Drug release is mediated by a
Fig. 9 – Steps in AxxessTM stent deployment. Step 1:
AxxessTM stent positioned and sheath partially retracted
(both 1 proximal and 3 distal markers visible); Step 2:
Axxess stent advanced (both 1 proximal and 3 distal
markers visible; Step 3: Sheath fully retracted and stent
deployed. The proximal and distal markers span the extent
of stent and position with the vessels.
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olized over time into carbon dioxide and water within 6–9
months) applied to the abluminal surface of the stent. The
nominal drug loading is 22 mg/mm of stent length for all sizes.
It is available in two lengths of 11 mm and 14 mm and two
diameters of 3 mm and 3.5 mm (Fig. 8).
3.8. Deployment sequence
1. Wire both branches of the lesion.
2. Pre-dilate MV, DMV, and the SB to provide space for the self-
expanding stent. The stent is inserted in the wire positioned
in the most angulated distal branch relative to the proximal
segment (or the branch expected to be more difﬁcult to re-
wire after AxxessTM stent placement (smaller, dissected or
more diseased branch).
3. The delivery system is positioned (kept in place by a
covering sheath) just distal to the bifurcation carina by
means of distal stent markers, which is clearly visible under
ﬂuoroscopy.
4. The removable sheath that covers the AxxessTM stent may
be retracted and AxxessTM stent deployment is initiated.
5. The sheath is partially retracted enough to expose the 3
markers (approximately 3 mm).
6. The stent is advanced forward in order to bridge the carina
as much as possible.
7. The sheath is fully retracted, and the stent is deployed
(Fig. 9).
4. Conclusions
There are several limitations of conventional bifurcation
techniques, which range from both anatomic and mechanis-
tic. 1-stent strategy is limited by lack of scaffolding in SB,
whereas 2-stent strategy may be limited by the result obtained
in MV. Dedicated bifurcation stents offer a logical solution to
this problem, but are limited by procedural complexity and the
limited choice and sizes of device available.
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